Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Deep learning models have shown strong performance in classifying Alzheimer's disease (AD) from R2* maps, but their decision-making remains opaque, raising concerns about interpretability. Previous studies suggest biases in model decisions, necessitating further analysis. This study uses Layer-wise Relevance Propagation (LRP) and spectral clustering to explore classifier decision strategies acro...
Alzheimer's Disease (AD) is a progressive neurodegenerative disorder that leads to dementia, and early intervention can greatly benefit from analyzing linguistic abnormalities. In this work, we explore the potential of Large Language Models (LLMs) as health assistants for AD diagnosis from patient-generated text using in-context learning (ICL), where tasks are defined through a few input-output ...
INTRODUCTION: Quantification of amyloid plaques (A), neurofibrillary tangles (T2), and neurodegeneration (N) using PET and MRI is critical for Alzhe...
Concurrent neurodegenerative and vascular pathologies pose a diagnostic challenge in the clinical setting, with histopathology remaining the definitiv...
Discrete state space diffusion models have shown significant advantages in applications involving discrete data, such as text and image generation. ...
Early detection of cognitive disorders such as Alzheimer's disease is critical for enabling timely clinical intervention and improving patient outco...
Recent studies have shown that integrating multimodal data fusion techniques for imaging and genetic features is beneficial for the etiological anal...
Previous works in the literature apply 3D spatial-only models on 4D functional MRI data leading to possible sub-par feature extraction to be used fo...
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) is linked to cognitive decline and dementia risk. We aimed to investigate...
There is an urgent need for the precise prediction of cerebral amyloidosis using noninvasive and accessible indicators to facilitate the early diagnos...
Neural networks are responsible for processing sensory stimuli and driving the synaptic activity required for brain function and behavior. This comput...
Proteomic studies have been instrumental in identifying brain, cerebrospinal fluid and plasma proteins associated with Alzheimer's disease (AD). Here,...
BACKGROUND: Considering the prevalence of Alzheimer's Disease (AD) among the aging population and the limited means of treatment, early detection emer...
Characterizing age-related alterations in brain networks is crucial for understanding aging trajectories and identifying deviations indicative of neur...
OBJECTIVE: To identify blood-based biomarkers and therapeutic targets for Alzheimer's disease (AD) by leveraging single-cell RNA sequencing (scRNA-seq...
Deformable brain templates are an important tool in many neuroimaging analyses. Conditional templates (e.g., age-specific templates) have advantages o...
INTRODUCTION: The study aimed to develop and validate the Emergency Department Dementia Algorithm (EDDA) to detect dementia among older adults (65+) a...
Positron emission tomography (PET) imaging technology is widely used for diagnosing Alzheimer's disease (AD) in people with dementia. Although various...
Alzheimer's disease (AD) is a progressive neurological disorder characterized by cognitive decline due to brain cell death, typically manifesting late...
BACKGROUND: Dementia has an impact on the quality of life (QoL) of people with dementia. Tailored services are crucial for improving their QoL. Advanc...